All::Gastroenterology::Diseases::Primary biliary cholangitis
Intro
What is the common presentation of Primary biliary cholangitis?
The classic presentation is itching in a middle-aged woman
What patient groups is Primary biliary cholangitis most common?
middle-aged females (female:male ratio of 9:1)
What are the main clinical features of Primary biliary cholangitis?
- early: may be asymptomatic (e.g. raised ALP on routine LFTs) or fatigue, pruritus
- cholestatic jaundice
- hyperpigmentation, especially over pressure points
- around 10% of patients have right upper quadrant pain
- xanthelasmas, xanthomata
- also: clubbing, hepatosplenomegaly
- late: may progress to liver failure
How is Primary biliary cholangitis diagnosed?
- immunology
- anti-mitochondrial antibodies (AMA) M2 subtype are present in 98% of patients and are highly specific
- smooth muscle antibodies in 30% of patients
- raised serum IgM
- imaging
- required before diagnosis to exclude an extrahepatic biliary obstruction (USS/MRCP)
What is the management of Primary biliary cholangitis?
- first-line: ursodeoxycholic acid
- slows disease progression and improves symptoms
- pruritus: cholestyramine
- fat-soluble vitamin supplementation
- liver transplantation
- e.g. if bilirubin > 100 (PBC is a major indication)
- recurrence in graft can occur but is not usually a problem
What are the main causes of Primary biliary cholangitis?
thought to be an autoimmune condition
What is the pathophysiology of Primary biliary cholangitis?
Interlobular bile ducts become damaged by a chronic inflammatory process causing progressive cholestasis which may eventually progress to cirrhosis
What are the main associations of Primary biliary cholangitis?
- Sjogren's syndrome (seen in up to 80% of patients)
- rheumatoid arthritis
- systemic sclerosis
- thyroid disease
What are the common complications of Primary biliary cholangitis?
- cirrhosis → portal hypertension → ascites, variceal haemorrhage
- osteomalacia and osteoporosis
- significantly increased risk of hepatocellular carcinoma (20-fold increased risk)